Todd Franklin Watanabe - 20 Dec 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Reporting Person's title: Chief Executive Officer and President, Director
Signature
/s/ John W. Smither, as Attorney-in-Fact for Todd Franklin Watanabe
Issuer symbol
ARQT
Transactions as of
20 Dec 2023
Net transactions value
$0
Form type
4
Filing time
22 Dec 2023, 17:24:26 UTC
Previous filing
01 Dec 2023
Next filing
17 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Gift $0 -6,563 -1.3% $0.000000 508,582 20 Dec 2023 Direct
transaction ARQT Common Stock Gift $0 -6,563 -1.3% $0.000000 502,019 20 Dec 2023 Direct
transaction ARQT Common Stock Gift $0 +6,563 +37% $0.000000 24,413 20 Dec 2023 By Trust F1
transaction ARQT Common Stock Gift $0 +6,563 +37% $0.000000 24,413 20 Dec 2023 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.
F2 The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.

Remarks:

Reporting Person's title: Chief Executive Officer and President